Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., discusses cannabinoid-based drug pipeline.

October 17, 2018 admin CEO Interview, Healthcare Comments Off on Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., discusses cannabinoid-based drug pipeline.

tetra logo

 

 

 

Guy Chamberland

 

 

 

 

 

Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative.

Investor Presentation Deck
[pdf-embedder url=”http://www.wallstreetreporter.com/wp-content/uploads/2018/10/Tetra-Investor-Presentation.pdf” title=”Tetra Investor Presentation”]




Related Articles

Consumer

Yield Growth (OTC: BOSQF) Garners Positive Reviews in Top Magazines ELLE Canada and Zoomer for its Urban Juve Anti-Aging Serum

April 11, 2019 admin Consumer, Newsmakers Comments Off on Yield Growth (OTC: BOSQF) Garners Positive Reviews in Top Magazines ELLE Canada and Zoomer for its Urban Juve Anti-Aging Serum

VANCOUVER, British Columbia, April 09, 2019 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE: BOSS) (OTC: BOSQF) (frankfurt:YG3) announces its subsidiary Urban Juve has received positive national media attention from two of Canada’s leading lifestyle magazines […]

Newsmakers

Check-Cap (NASDAQ: CHEK) Announces Pricing of $17.5 Million Upsized Underwritten Public Offering

May 5, 2018 admin Newsmakers Comments Off on Check-Cap (NASDAQ: CHEK) Announces Pricing of $17.5 Million Upsized Underwritten Public Offering

ISFIYA, Israel, May 04, 2018 — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW, CHEKZ), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, […]